Aeromonas hydrophila in Fish Farming: Pathogenicity and Antimicrobial Resistance

Introduction

Aeromonas hydrophila is a Gram-negative, facultatively anaerobic, rod-shaped bacterium belonging to the family Aeromonadaceae. It is ubiquitously distributed in freshwater and brackish water environments and constitutes a significant component of the autochthonous microbiota of fish. Under conditions of host immunosuppression, environmental stress, or mucosal barrier disruption, A. hydrophila transitions from a commensal to a primary pathogen, causing hemorrhagic septicemia, motile aeromonad septicemia (MAS), and ulcerative syndrome in a wide range of cultured freshwater fish species including cyprinids, tilapias, catfish, and salmonids [1, 2]. The economic impact of A. hydrophila outbreaks in global aquaculture is substantial, with mortality rates exceeding 80 percent in acute epizootics and chronic production losses associated with subclinical infections [3, 4]. This article provides a comprehensive, mechanism-based review of A. hydrophila pathogenicity, clinical disease presentation, diagnostic modalities, and the escalating challenge of antimicrobial resistance.

Taxonomy and Microbiological Characteristics

Aeromonas hydrophila is a member of the Aeromonas genus, which comprises at least 36 recognized species classified within the class Gammaproteobacteria. The species A. hydrophila is phenotypically heterogeneous and is subdivided into two subspecies: A. hydrophila subsp. hydrophila and A. hydrophila subsp. dhakensis (now reclassified as Aeromonas dhakensis by some taxonomists) [5]. The bacterium is motile via a single polar flagellum, grows optimally at temperatures between 25 and 35 degrees Celsius, and produces a variety of extracellular enzymes including proteases, lipases, and hemolysins that contribute to tissue degradation and invasion [6, 7].

Colonial morphology on standard bacteriological media such as tryptic soy agar (TSA) or blood agar is characterized by large, smooth, cream-colored colonies that may be beta-hemolytic on sheep blood agar. On selective media such as Rimler-Shotts agar, colonies appear yellow to green depending on the substrate utilization profile. Aeromonas hydrophila ferments D-glucose with acid production, is oxidase-positive, catalase-positive, and reduces nitrate to nitrite [8].

Pathogenicity Mechanisms

Adhesion and Biofilm Formation

The initial step in A. hydrophila infection involves adhesion to host epithelial surfaces, primarily the skin, gills, and gastrointestinal mucosa. Adhesion is mediated by a suite of surface structures including the polar flagellum, type IV pili, and outer membrane proteins (OMPs) such as OmpA and OmpW [9, 10]. Following adherence, the bacterium forms a three-dimensional biofilm matrix composed of exopolysaccharides, proteins, and extracellular DNA (eDNA). The biofilm state confers resistance to both host immune defenses and antimicrobial agents by limiting diffusion and promoting a persister cell phenotype [11, 12].

Extracellular Toxins and Enzymes

Aeromonas hydrophila secretes a diverse arsenal of exotoxins and hydrolytic enzymes that mediate tissue damage and immune evasion. The pore-forming toxin aerolysin (AerA) is the most extensively characterized virulence factor. Aerolysin binds to glycosylphosphatidylinositol (GPI)-anchored proteins on host cell membranes, oligomerizes to form heptameric pores, and induces osmotic lysis of erythrocytes, epithelial cells, and leukocytes [13, 14]. Hemolysins (HlyA, HlyB) and cytotoxins (Act) contribute to hemorrhagic necrosis of internal organs. Additionally, secreted proteases including serine protease (Prt) and metalloprotease (Mpr) degrade host connective tissue components and activate aerolysin zymogen [15, 16].

Secretion Systems

Aeromonas hydrophila possesses multiple macromolecular secretion systems that translocate virulence effectors directly into host cells. The type III secretion system (T3SS) is a syringe-like apparatus that injects effector proteins such as AexT, AexU, and AopP into the host cytosol, modulating actin cytoskeleton dynamics, inhibiting phagocytosis, and suppressing NF-kappaB signaling [17, 18]. The type VI secretion system (T6SS) mediates interbacterial competition and host cell manipulation through the delivery of antibacterial effectors such as VgrG and Hcp [19]. The type II secretion system (T2SS) is responsible for the extracellular export of aerolysin and degradative enzymes [20].

Iron Acquisition Systems

Iron is an essential cofactor for bacterial metabolism and is sequestered by host iron-binding proteins during infection. Aeromonas hydrophila expresses multiple siderophore-mediated iron acquisition systems, including the catecholate siderophore amonabactin and the hydroxamate siderophore aerobactin [21]. These high-affinity iron chelators compete with host transferrin and lactoferrin, enabling bacterial proliferation within the iron-limited environment of host tissues. Outer membrane receptors (e.g., FhuA, FepA) mediate the active transport of iron-siderophore complexes into the periplasm [22].

Clinical Signs and Pathogenesis in Fish

Acute Hemorrhagic Septicemia

The most characteristic clinical manifestation of A. hydrophila infection in cultured fish is acute hemorrhagic septicemia, also referred to as motile aeromonad septicemia (MAS). Affected fish present with bilateral exophthalmos, distended abdomen (ascites), erythema at the base of fins and around the vent, and petechial hemorrhages on the skin, gills, and internal organs [23, 24]. Internally, necropsy reveals hepatomegaly with a friable, mottled liver, splenomegaly, hemorrhagic enteritis, and accumulation of serosanguinous fluid in the peritoneal cavity. Histopathological findings include multifocal hepatic necrosis, renal tubular degeneration, and branchial epithelial hyperplasia with lamellar fusion [25, 26].

Chronic Ulcerative Syndrome

A chronic form of disease characterized by focal dermal ulcers and muscle necrosis is observed in older or partially resistant fish. Lesions typically originate as small erythematous foci that progress to deep, necrotic ulcers extending into the underlying musculature. Secondary invasion by opportunistic pathogens such as Saprolegnia spp. exacerbates tissue destruction and delays healing [27]. Chronic infections lead to reduced feed conversion efficiency, growth retardation, and increased susceptibility to additional stressors.

Coinfections and Predisposing Factors

The transition from commensalism to pathogenicity is driven by environmental and host-related stressors including elevated water temperature (above 25 degrees Celsius), hypoxia, ammonia accumulation, high stocking density, and concurrent infections with parasites such as Ichthyophthirius multifiliis (Ich) in Freshwater Aquaculture: Rapid Detection and Integrated Control [28]. Coinfections with other bacterial pathogens, including species within the genus Aeromonas and Mycobacterium marinum Infections in Aquatic Animals and Humans: Pathogenesis, Diagnostics, and Zoonotic Implications, compound disease severity and complicate clinical diagnosis.

Diagnostic Approaches

Culture and Biochemical Identification

Definitive diagnosis of A. hydrophila infection requires isolation of the organism in pure culture from affected tissues such as kidney, spleen, or liver. Samples are streaked onto TSA, blood agar, or selective media such as Rimler-Shotts agar or ampicillin-dextrin agar and incubated aerobically at 28 degrees Celsius for 24 to 48 hours [29]. Suspect colonies are subcultured and subjected to biochemical profiling using commercial identification systems or standard tube-based tests. Key biochemical characteristics include oxidase positivity, catalase positivity, esculin hydrolysis, L-arabinose and D-mannitol fermentation, and resistance to the vibriostatic agent O/129 (2,4-diamino-6,7-diisopropylpteridine) [30].

Molecular Detection

Nucleic acid-based methods offer superior sensitivity and specificity compared to culture, particularly in cases where antimicrobial therapy has been initiated or when the bacterial burden is low. Polymerase chain reaction (PCR) assays targeting the 16S rRNA gene, the aerolysin gene (aerA), the hemolysin gene (hlyA), and the gyrase B gene (gyrB) are widely used for species-level identification of A. hydrophila [31, 32]. Real-time quantitative PCR (qPCR) allows quantification of bacterial load in tissue samples and water samples, facilitating monitoring of subclinical infections. Multiplex PCR panels that simultaneously detect aerA, hlyA, and the lipase gene (lip) enable simultaneous genotyping of virulence determinants [33].

Serological Methods

Enzyme-Linked Immunosorbent Assay (ELISA) for Feline Leukemia Virus platforms have been adapted for detection of A. hydrophila antigens in fish tissues and pond water. Monoclonal antibodies directed against the lipopolysaccharide (LPS) O-antigen or aerolysin provide moderate sensitivity and are used primarily for surveillance and outbreak confirmation [34]. Latex agglutination assays and lateral flow immunochromatographic strips have been developed for point-of-care application in field settings, although their diagnostic accuracy is variable.

Antibiogram Profiling

Determination of antimicrobial susceptibility is essential for guiding empirical therapy and monitoring resistance trends. Disk diffusion and broth microdilution methods following Clinical and Laboratory Standards Institute (CLSI) guidelines VET04 and M07 are used to generate minimum inhibitory concentration (MIC) values for a panel of antimicrobial agents including oxytetracycline, florfenicol, enrofloxacin, sulfadimethoxine-ormetoprim, and amoxicillin [35]. Interpretation criteria for aquatic species are based on CLSI veterinary breakpoints.

The following diagnostic workflow illustrates the sequential steps in confirming A. hydrophila disease and characterizing antimicrobial resistance profiles.

flowchart TD
    A["Fish presenting with clinical signs suggestive of septicemia"], > B["Necropsy and sterile tissue sampling<br>(kidney, spleen, liver, ascitic fluid)"]
    B, > C["Bacterial culture on<br>TSA, blood agar, or selective media<br>28 degrees C, 24-48 h"]
    C, > D["Colony morphology and<br>Gram stain: Gram-negative rods"]
    D, > E{"Oxidase test"}
    E, >|Positive| F["Biochemical identification<br>(API 20E, conventional tests)"]
    E, >|Negative| G["Consider other pathogens<br>(Pseudomonas, Vibrio, Edwardsiella)"]
    F, > H{"Molecular confirmation<br>(PCR: aerA, hlyA, gyrB)"}
    H, >|Positive| I["Confirmed A. hydrophila<br>virulence genotyping"]
    H, >|Negative| G
    I, > J["Antimicrobial susceptibility testing<br>(disk diffusion or broth microdilution)"]
    J, > K["MDR profile identification<br>and therapeutic adjustment"]
    K, > L["Biosecurity interventions and<br>vaccination protocol review"]

Antimicrobial Resistance

Global Resistance Patterns

The intensive use of antimicrobial agents in aquaculture has selected for multidrug-resistant (MDR) strains of A. hydrophila worldwide. Resistance to tetracyclines, sulfonamides, and quinolones is prevalent among isolates recovered from Asian, African, and South American aquaculture systems [36, 37]. A systematic analysis of peer-reviewed reports indicates that resistance rates for oxytetracycline exceed 60 percent in certain regions, while florfenicol resistance is emerging at frequencies of 10 to 30 percent [38]. Fluoroquinolone resistance, mediated by mutations in DNA gyrase (gyrA) and topoisomerase IV (parC) genes, is documented in both clinical and environmental isolates [39].

Molecular Mechanisms of Resistance

The genetic basis of antimicrobial resistance in A. hydrophila involves a combination of point mutations, acquisition of mobile genetic elements, and upregulation of efflux pumps. Plasmid-mediated resistance determinants include tet(A), tet(E), and tet(34) for tetracyclines; sul1, sul2, and sul3 for sulfonamides; and floR for florfenicol [40, 41]. Integrons, particularly class 1 integrons carrying gene cassettes encoding aminoglycoside-modifying enzymes and dihydrofolate reductase variants, are commonly identified in MDR isolates [42]. The outer membrane permeability barrier in A. hydrophila is modulated by downregulation of porin proteins such as OmpF, reducing antibiotic influx and contributing to intrinsic resistance to beta-lactams and macrolides [43].

Efflux Pump Systems

Resistance-nodulation-division (RND) efflux pumps, including the AcrAB-TolC system, are constitutively expressed in A. hydrophila and contribute to multidrug resistance by extruding structurally diverse antimicrobial agents. Overexpression of acrB and acrF genes correlates with reduced susceptibility to tetracyclines, fluoroquinolones, and chloramphenicol [44]. The synergistic action of efflux pumps and enzymatic inactivation mechanisms (e.g., beta-lactamases such as AmpC and extended-spectrum beta-lactamases) creates a formidable resistance phenotype that limits therapeutic options [45].

One Health and Resistance Dissemination

The aquatic environment serves as a reservoir for antimicrobial resistance genes (ARGs) that can be transferred to human-associated bacterial populations via horizontal gene transfer. Aeromonas hydrophila harbors plasmids and transposons containing ARGs with high sequence homology to those found in Antimicrobial Resistance in Livestock-Associated Staphylococcus aureus: Genomic Epidemiology and One Health Implications and other clinically significant taxa [46]. The presence of identical resistance determinants in A. hydrophila, Escherichia coli, and Salmonella enterica underscores the interconnectedness of aquatic, terrestrial, and human microbiomes.

Management and Control Strategies

Biosecurity Measures

Prevention of A. hydrophila outbreaks relies on stringent biosecurity protocols including quarantine of incoming stock, disinfection of equipment and water sources, and maintenance of optimal water quality parameters. Reduction of stocking density, avoidance of abrupt temperature shifts, and removal of moribund fish limit horizontal transmission. Probiotic bacteria such as Bacillus subtilis and Lactobacillus spp. have been shown to competitively exclude A. hydrophila from the gastrointestinal tract and reduce colonization density [47, 48].

Vaccination

Inactivated whole-cell vaccines and subunit vaccines based on recombinant OMPs (e.g., OmpA, OmpW) and aerolysin toxoids have been evaluated in experimental and field trials. Oral and immersion delivery routes are preferred for mass vaccination of fry and fingerlings. While vaccine efficacy is variable due to antigenic diversity among A. hydrophila strains, multivalent formulations incorporating conserved antigens improve cross-protection [49].

Alternative Therapeutic Approaches

Given the widespread dissemination of MDR strains, research attention has shifted toward alternative antimicrobial strategies. Bacteriophage therapy using lytic phages specific to A. hydrophila has demonstrated efficacy in reducing mortality in experimentally infected fish. Phage cocktails targeting multiple receptor types minimize the emergence of phage-resistant mutants [50]. Antimicrobial peptides (AMPs) derived from fish immune cells and synthetic AMPs are under investigation as adjunctive or replacement therapies. Biological Foundation Models for Antimicrobial Peptide Discovery in Veterinary Pathogens accelerate the identification of novel AMP candidates through computational screening and structure-activity relationship modeling.

Conclusion

Aeromonas hydrophila remains a dominant bacterial pathogen in freshwater aquaculture, causing substantial economic losses through acute hemorrhagic septicemia and chronic ulcerative disease. Its pathogenesis is driven by a multifaceted arsenal of adhesins, exotoxins, secretion systems, and iron acquisition mechanisms that enable colonization, tissue destruction, and immune evasion. Diagnosis requires a combination of culture-based isolation, biochemical profiling, and molecular confirmation using PCR targeting aerolysin and hemolysin genes. Antibiogram testing is essential for monitoring the expanding spectrum of antimicrobial resistance, which is mediated by plasmid-borne ARGs, integron cassettes, and upregulated efflux pumps. Integrated management combining biosecurity, vaccination, and alternative therapeutics such as bacteriophages and antimicrobial peptides is necessary to mitigate the impact of MDR A. hydrophila in fish farming systems. Continued genomic surveillance and functional characterization of resistance mechanisms will inform the development of sustainable control strategies.

References

[1] Janda JM, Abbott SL. The genus Aeromonas: taxonomy, pathogenicity, and infection. Clinical Microbiology Reviews.

[2] Austin B, Austin DA. Bacterial Fish Pathogens: Disease of Farmed and Wild Fish. Springer.

[3] Cipriano RC, Bullock GL, Pyle SW. Aeromonas hydrophila and motile aeromonad septicemias of fish. Fish Disease Leaflet.

[4] Harikrishnan R, Balasundaram C, Heo MS. Fish health aspects in aquaculture: a review. Fish and Shellfish Immunology.

[5] Beaz-Hidalgo R, Figueras MJ. Aeromonas spp. whole genomes and virulence factors implicated in fish disease. Journal of Fish Diseases.

[6] Tomás JM. The main Aeromonas pathogenic factors. International Microbiology.

[7] Pemberton JM, Kidd SP, Schmidt R. Secreted enzymes of Aeromonas. FEMS Microbiology Letters.

[8] Abbott SL, Cheung WK, Janda JM. The genus Aeromonas: biochemical characteristics, API 20E identification, and phenotypic methods. Journal of Clinical Microbiology.

[9] Kirov SM. Bacteria that express lateral flagella enable dissection of the multifunctional roles of flagella in pathogenesis. FEMS Microbiology Letters.

[10] Namba A, Mano N, Hirose H, et al. Role of OmpA and OmpW in adhesion and biofilm formation of Aeromonas hydrophila. Journal of Applied Microbiology.

[11] Lynch MJ, Swift S, Kirke DF, et al. Biofilm formation and quorum sensing in Aeromonas hydrophila. Journal of Fish Diseases.

[12] Costerton JW, Stewart PS, Greenberg EP. Bacterial biofilms: a common cause of persistent infections. Science.

[13] Buckley JT, Howard SP. The cytotoxic enterotoxin of Aeromonas hydrophila is aerolysin. Infection and Immunity.

[14] Abrami L, Fivaz M, van der Goot FG. Adventures of a pore-forming toxin at the target cell surface. Trends in Microbiology.

[15] Cascón A, Yugueros J, Temprano A, et al. A major secreted elastase is essential for pathogenicity of Aeromonas hydrophila. Infection and Immunity.

[16] Mateos D, Anguita J, Naharro G, et al. Cloning and characterization of a serine protease gene from Aeromonas hydrophila. FEMS Microbiology Letters.

[17] Burr SE, Stuber K, Wahli T, et al. Evidence for a type III secretion system in Aeromonas hydrophila. International Journal of Medical Microbiology.

[18] Vilches S, Jimenez N, Tomas JM, et al. The type III secretion system of Aeromonas hydrophila: a role for AexU in virulence. Microbiology.

[19] Suarez G, Sierra JC, Erova TE, et al. A type VI secretion system effector protein, VgrG1, from Aeromonas hydrophila that induces host cell toxicity. Journal of Biological Chemistry.

[20] Sandkvist M. Type II secretion and pathogenesis. Infection and Immunity.

[21] Byers BR, Massad G, Barghouthi S, et al. Iron acquisition and virulence in the motile aeromonads. BioMetals.

[22] Stintzi A, Raymond KN. Amonabactin-mediated iron acquisition in Aeromonas hydrophila. Journal of the American Chemical Society.

[23] Roberts RJ. Fish Pathology. Wiley-Blackwell.

[24] Noga EJ. Fish Disease: Diagnosis and Treatment. Wiley-Blackwell.

[25] Ferguson HW. Systemic Pathology of Fish. Iowa State University Press.

[26] Wolf JC, Baumgartner WA, Blazer VS, et al. Histopathology of aeromonad infections in fish. Veterinary Pathology.

[27] Densmore CL, Green DE. Diseases of amphibians. ILAR Journal.

[28] Johansson N, Svensson E, Norrgren L, et al. Effects of environmental stressors on susceptibility to Aeromonas hydrophila infection. Aquaculture.

[29] Shotts EB, Rimler R. Medium for the isolation of Aeromonas hydrophila. Applied Microbiology.

[30] Popoff M. Genus III. Aeromonas. Bergey's Manual of Systematic Bacteriology.

[31] Kingombe CI, Huys G, Tonolla M, et al. PCR detection, characterization, and distribution of virulence genes in Aeromonas spp. Applied and Environmental Microbiology.

[32] Bin Kingombe CI, D'Aoust JY, Huys G, et al. Multiplex PCR for detection of virulence genes in Aeromonas hydrophila. Journal of Clinical Microbiology.

[33] Nawaz M, Khan SA, Khan AA, et al. Detection and characterization of virulence genes in Aeromonas hydrophila strains. International Journal of Food Microbiology.

[34] Kozinska A, Antychowicz J, Furowicz AJ, et al. ELISA for detection of Aeromonas hydrophila antigens in fish tissues. Journal of Veterinary Diagnostic Investigation.

[35] Clinical and Laboratory Standards Institute. Methods for Broth Dilution Susceptibility Testing of Bacteria Isolated from Aquatic Animals. CLSI document VET04.

[36] Scarano C, Spanu V, Ziino G, et al. Antibiotic resistance of Aeromonas hydrophila isolated from fish and seafood. Italian Journal of Food Safety.

[37] Vivekanandhan G, Savithamani K, Hatha AA, et al. Antibiotic resistance of Aeromonas hydrophila isolated from marketed fish. Asian Fisheries Science.

[38] Dobiasova H, Kutilova I, Krizova L, et al. Antibiotic resistance in Aeromonas hydrophila from Czech aquaculture. Veterinary Microbiology.

[39] Giraud E, Blanc G, Bouju-Albert A, et al. Mechanisms of quinolone resistance in Aeromonas hydrophila. Antimicrobial Agents and Chemotherapy.

[40] Schmidt AS, Bruun MS, Dalsgaard I, et al. Occurrence of antimicrobial resistance in Aeromonas hydrophila from Danish aquaculture. Journal of Fish Diseases.

[41] Gordon L, Giraud E, Ganiere JP, et al. Antimicrobial resistance patterns and plasmid-mediated resistance genes in Aeromonas hydrophila. Veterinary Research.

[42] Chang TM, Lin CC, Chang YF, et al. Class 1 integrons and antimicrobial resistance in Aeromonas hydrophila isolates. Journal of Antimicrobial Chemotherapy.

[43] Fàbrega A, Sánchez-Céspedes J, Soto S, et al. Outer membrane porins in bacterial drug resistance. Antimicrobial Agents and Chemotherapy.

[44] Hernould M, Gagné S, Fournier D, et al. Role of AcrAB-TolC efflux pump in Aeromonas hydrophila resistance. Journal of Medical Microbiology.

[45] Poirel L, Bonnin RA, Nordmann P. Genetic support and diversity of acquired extended-spectrum beta-lactamases in Aeromonas spp. Clinical Microbiology Reviews.

[46] Baquero F, Martínez JL, Cantón R. Antibiotics and antibiotic resistance in water environments. Current Opinion in Biotechnology.

[47] Verschuere L, Rombaut G, Sorgeloos P, et al. Probiotic bacteria as biological control agents in aquaculture. Microbiology and Molecular Biology Reviews.

[48] Balcázar JL, de Blas I, Ruiz-Zarzuela I, et al. The role of probiotics in aquaculture. Veterinary Microbiology.

[49] Sudheesh PS, Al-Ghabshi A, Al-Mazrooei N, et al. Comparative evaluation of vaccine efficacy against Aeromonas hydrophila in fish. Fish and Shellfish Immunology.

[50] Oliveira J, Castilho F, Cunha A, et al. Bacteriophage therapy as an alternative for controlling Aeromonas hydrophila infections. Aquaculture Research.